All Stories

  1. Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study
  2. Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the EMMY trial
  3. Glycated haemoglobin, HOMA2‐B, C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis
  4. Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases—A Retrospective Analysis
  5. Timing of SGLT2i initiation after acute myocardial infarction
  6. Effects of 8 weeks of aerobic endurance training on functional capacity and metabolic variables in people with type 1 diabetes: A secondary outcome analysis of the ULTRAFLEXI‐1 study
  7. Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
  8. Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
  9. Resilience in Pakistani undergraduate nursing students: An exploratory descriptive study
  10. SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction
  11. Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study
  12. Effects of empagliflozin in women and men with acute myocardial infarction – an analysis from the EMMY trial
  13. Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People—A Cohort Trial
  14. Burnout and psychological distress among Pakistani nurses providing care to COVID‐19 patients: A cross‐sectional study